English

POLAR MOLECULAR HOLDING CORP

EDGAR

Filing (10KSB) · filed 2006-01-09

42 filing records in this dataset, filed from 1996-12-10 to 2006-01-09. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

65 thousand USD

2004-12-31 · USD

Exact inputs and evidence

Revenue: 408000 USD Source
Revenue: 343000 USD Source

Operating margin

-923.08%

2004-12-31 · %

Exact inputs and evidence

Operating Income: -2793000 USD Source
Operating Income: -2193000 USD Source
Revenue: 408000 USD Source
Revenue: 343000 USD Source

Operating cash flow

-244 thousand USD

2004-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -1121000 USD Source
Operating Cash Flow: -877000 USD Source

Cash and cash equivalents: 0 USD 2004-12-31 Source
Exact value

0 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

408 thousand USD

2004-01-01 – 2004-12-31

Exact inputs and evidence

Revenue: 90000 USD · 2004-01-01 – 2004-03-31 Source
Revenue: 99000 USD · 2004-04-01 – 2004-06-30 Source
Revenue: 154000 USD · 2004-07-01 – 2004-09-30 Source
Revenue: 408000 USD · 2004-01-01 – 2004-12-31 Source
Revenue: 343000 USD · 2004-01-01 – 2004-09-30 Source

Net income

-3.2 million USD

2004-01-01 – 2004-12-31

Exact inputs and evidence

Net income: -767000 USD · 2004-01-01 – 2004-03-31 Source
Net income: -1474000 USD · 2004-04-01 – 2004-06-30 Source
Net income: -285000 USD · 2004-07-01 – 2004-09-30 Source
Net income: -3195000 USD · 2004-01-01 – 2004-12-31 Source
Net income: -2526000 USD · 2004-01-01 – 2004-09-30 Source

Operating cash flow

-1.12 million USD

2004-01-01 – 2004-12-31

Exact inputs and evidence

Operating cash flow: -250000 USD · 2004-01-01 – 2004-03-31 Source
Operating cash flow: -876000 USD · 2004-01-01 – 2004-06-30 Source
Operating cash flow: -250000 USD · 2004-01-01 – 2004-03-31 Source
Operating cash flow: -877000 USD · 2004-01-01 – 2004-09-30 Source
Operating cash flow: -876000 USD · 2004-01-01 – 2004-06-30 Source
Operating cash flow: -1121000 USD · 2004-01-01 – 2004-12-31 Source
Operating cash flow: -877000 USD · 2004-01-01 – 2004-09-30 Source

Capital expenditure

16 thousand USD

2003-10-01 – 2004-09-30

Exact inputs and evidence

Capital expenditure: 2000 USD · 2003-01-01 – 2003-12-31 Source
Capital expenditure: 0 USD · 2003-01-01 – 2003-09-30 Source
Capital expenditure: 5000 USD · 2004-01-01 – 2004-03-31 Source
Capital expenditure: 14000 USD · 2004-01-01 – 2004-06-30 Source
Capital expenditure: 5000 USD · 2004-01-01 – 2004-03-31 Source
Capital expenditure: 14000 USD · 2004-01-01 – 2004-09-30 Source
Capital expenditure: 14000 USD · 2004-01-01 – 2004-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2006-01-09.

Financial data available through: 2004-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2004-12-31
Operating income: 5 of 11 periods available· newest 2004-12-31
Net income: 5 of 11 periods available· newest 2004-12-31
Operating cash flow: 5 of 11 periods available· newest 2004-12-31
Capital expenditure: 5 of 11 periods available· newest 2004-12-31
Total assets: 4 of 11 periods available· newest 2004-12-31
Total liabilities: 3 of 11 periods available· newest 2002-03-31
Current assets: 5 of 11 periods available· newest 2004-12-31
Current liabilities: 5 of 11 periods available· newest 2004-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2004-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-1.9%

Prior period

USD 416,000

2003-01-01 – 2003-12-31
Current period

USD 408,000

2004-01-01 – 2004-12-31

Exact inputs and evidence

408000 − 416000 = -8000 USD

416000 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
408000 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · POLAR MOLECULAR HOLDING CORP · 2004-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Year-over-year change in Revenue: -8000 USD Concept: fundies:Revenue Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 408000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#10449 Input fundies:Revenue: 416000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#10449
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 124,000

Prior period

−USD 3.32 million

2003-01-01 – 2003-12-31
Current period

−USD 3.2 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

-3195000 − -3319000 = 124000 USD

-3319000 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
-3195000 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · POLAR MOLECULAR HOLDING CORP · 2004-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Year-over-year change in Net income: 124000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -3195000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13252 Input fundies:NetIncome: -3319000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13252
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 356,000

Prior period

−USD 765,000

2003-01-01 – 2003-12-31
Current period

−USD 1.12 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

-1121000 − -765000 = -356000 USD

-765000 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
-1121000 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · POLAR MOLECULAR HOLDING CORP · 2004-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Year-over-year change in Operating cash flow: -356000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1121000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13709 Input fundies:OperatingCashFlow: -765000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13709
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+50%

Prior period

USD 2,000

2003-01-01 – 2003-12-31
Current period

USD 3,000

2004-01-01 – 2004-12-31

Exact inputs and evidence

3000 − 2000 = 1000 USD

2000 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
3000 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · POLAR MOLECULAR HOLDING CORP · 2004-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Year-over-year change in Capital expenditure: 1000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13814 Input fundies:CapitalExpenditure: 2000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13814
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2004 2004-01-01 – 2004-12-31

Revenue USD 408,000 100% of revenue
Operating costs Derived USD 3.2 million 785% of revenue
Operating income −USD 2.79 million −685% of revenue
Tax, interest and other Derived USD 402,000 99% of revenue
Net income −USD 3.2 million −783% of revenue

Cash

Operating cash flow −USD 1.12 million −275% of revenue
Capital expenditure USD 3,000 0.7% of revenue
Free cash flow Derived −USD 1.12 million −275% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 Operating loss: operating costs were 114% of revenue.
1996 Operating loss: operating costs were 126% of revenue.
2002 Operating loss: operating costs were 1,241% of revenue.
2003 Operating loss: operating costs were 794% of revenue.
2004 Operating loss: operating costs were 785% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1995-01-01 – 1995-12-31	8916563	10133760 Derived	-1217197	1307210 Derived	-2524407	1194865 Derived	Source 1995-01-01 – 1995-12-31: 8916563 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -1217197 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -2524407 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: 1453364 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 258499 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	8164602	10280236 Derived	-2115634	372005 Derived	-2487639	-2520930 Derived	Source 1996-01-01 – 1996-12-31: 8164602 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -2115634 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -2487639 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -1307460 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 1213470 USD Inspect Capital Expenditure Open source
2002 2001-04-01 – 2002-03-31	162000	2011000 Derived	-1849000	97000 Derived	-1946000	-313000 Derived	Source 2001-04-01 – 2002-03-31: 162000 USD Inspect Revenue Open source 2001-04-01 – 2002-03-31: -1849000 USD Inspect Operating Income Open source 2001-04-01 – 2002-03-31: -1946000 USD Inspect Net Income Open source 2001-04-01 – 2002-03-31: -311000 USD Inspect Operating Cash Flow Open source 2001-04-01 – 2002-03-31: 2000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	416000	3304000 Derived	-2888000	431000 Derived	-3319000	-767000 Derived	Source 2003-01-01 – 2003-12-31: 416000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -2888000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -3319000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -765000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 2000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	408000	3201000 Derived	-2793000	402000 Derived	-3195000	-1124000 Derived	Source 2004-01-01 – 2004-12-31: 408000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -2793000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -3195000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -1121000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 3000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 408K 2004

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Revenue	8916563	Revenue: 8916563 Open source
19961996-12-31	Revenue	8164602	Revenue: 8164602 Open source
20022002-03-31	Revenue	162000	Revenue: 162000 Open source
20032003-12-31	Revenue	416000	Revenue: 416000 Open source
20042004-12-31	Revenue	408000	Revenue: 408000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-1.9% 2004

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Year over year	No prior comparable period	Revenue: 8916563 Open source
19961996-12-31	Year over year	-8.4%	Revenue: 8164602 Open source Revenue: 8916563 Open source
20022002-03-31	Year over year	No prior comparable period	Revenue: 162000 Open source
20032003-12-31	Year over year	No prior comparable period	Revenue: 416000 Open source
20042004-12-31	Year over year	-1.9%	Revenue: 408000 Open source Revenue: 416000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -684.6% 2004

Net margin -783.1% 2004

Free cash flow margin -275.5% 2004

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Operating margin	-13.7%	Operating Income: -1217197 Open source Revenue: 8916563 Open source
19961996-12-31	Operating margin	-25.9%	Operating Income: -2115634 Open source Revenue: 8164602 Open source
20022002-03-31	Operating margin	-1,141.4%	Operating Income: -1849000 Open source Revenue: 162000 Open source
20032003-12-31	Operating margin	-694.2%	Operating Income: -2888000 Open source Revenue: 416000 Open source
20042004-12-31	Operating margin	-684.6%	Operating Income: -2793000 Open source Revenue: 408000 Open source
19951995-12-31	Net margin	-28.3%	Net Income: -2524407 Open source Revenue: 8916563 Open source
19961996-12-31	Net margin	-30.5%	Net Income: -2487639 Open source Revenue: 8164602 Open source
20022002-03-31	Net margin	-1,201.2%	Net Income: -1946000 Open source Revenue: 162000 Open source
20032003-12-31	Net margin	-797.8%	Net Income: -3319000 Open source Revenue: 416000 Open source
20042004-12-31	Net margin	-783.1%	Net Income: -3195000 Open source Revenue: 408000 Open source
19951995-12-31	Free cash flow margin	13.4%	Revenue: 8916563 Open source Operating Cash Flow: 1453364 Open source Capital Expenditure: 258499 Open source
19961996-12-31	Free cash flow margin	-30.9%	Revenue: 8164602 Open source Operating Cash Flow: -1307460 Open source Capital Expenditure: 1213470 Open source
20022002-03-31	Free cash flow margin	-193.2%	Revenue: 162000 Open source Operating Cash Flow: -311000 Open source Capital Expenditure: 2000 Open source
20032003-12-31	Free cash flow margin	-184.4%	Revenue: 416000 Open source Operating Cash Flow: -765000 Open source Capital Expenditure: 2000 Open source
20042004-12-31	Free cash flow margin	-275.5%	Revenue: 408000 Open source Operating Cash Flow: -1121000 Open source Capital Expenditure: 3000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.1M 2004

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Operating cash flow	1453364	Operating Cash Flow: 1453364 Open source
19961996-12-31	Operating cash flow	-1307460	Operating Cash Flow: -1307460 Open source
20022002-03-31	Operating cash flow	-311000	Operating Cash Flow: -311000 Open source
20032003-12-31	Operating cash flow	-765000	Operating Cash Flow: -765000 Open source
20042004-12-31	Operating cash flow	-1121000	Operating Cash Flow: -1121000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.1M 2004

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Free cash flow	1194865	Operating Cash Flow: 1453364 Open source Capital Expenditure: 258499 Open source
19961996-12-31	Free cash flow	-2520930	Operating Cash Flow: -1307460 Open source Capital Expenditure: 1213470 Open source
20022002-03-31	Free cash flow	-313000	Operating Cash Flow: -311000 Open source Capital Expenditure: 2000 Open source
20032003-12-31	Free cash flow	-767000	Operating Cash Flow: -765000 Open source Capital Expenditure: 2000 Open source
20042004-12-31	Free cash flow	-1124000	Operating Cash Flow: -1121000 Open source Capital Expenditure: 3000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

84% 1996

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Liabilities / assets	156.4%	Total Liabilities: 11736566 Open source Total Assets: 7502561 Open source
19961996-12-31	Liabilities / assets	84%	Total Liabilities: 6280030 Open source Total Assets: 7479086 Open source
20022002-03-31	Liabilities / assets	Not reported	Total Liabilities: 20239000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 253000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 175000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.02× 2004

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Current assets / current liabilities	0.37×	Current Assets: 1579357 Open source Current Liabilities: 4312750 Open source
19961996-12-31	Current assets / current liabilities	1.28×	Current Assets: 2698909 Open source Current Liabilities: 2112728 Open source
20022002-03-31	Current assets / current liabilities	0×	Current Assets: 20000 Open source Current Liabilities: 15607000 Open source
20032003-12-31	Current assets / current liabilities	0.01×	Current Assets: 34000 Open source Current Liabilities: 4710000 Open source
20042004-12-31	Current assets / current liabilities	0.02×	Current Assets: 73000 Open source Current Liabilities: 4756000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1995 1995-01-01 – 1995-12-31	−USD 2.52 million Exact value Exact value: -2524407 USD 1995-01-01 – 1995-12-31: -2524407 USD Inspect Net Income Open source Share or cite Citation for Net Income · POLAR MOLECULAR HOLDING CORP · 1995-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Net Income: -2524407 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2524407 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0000950137-97-001373.txt#2304 The citation records this snapshot. The page link may show a newer release later.	USD 1.45 million Exact value Exact value: 1453364 USD 1995-01-01 – 1995-12-31: 1453364 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · POLAR MOLECULAR HOLDING CORP · 1995-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Operating Cash Flow: 1453364 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1453364 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0000950137-97-001373.txt#2320 The citation records this snapshot. The page link may show a newer release later.	USD 258,499 Exact value Exact value: 258499 USD 1995-01-01 – 1995-12-31: 258499 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · POLAR MOLECULAR HOLDING CORP · 1995-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Capital Expenditure: 258499 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 258499 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0000950137-97-001373.txt#2323 The citation records this snapshot. The page link may show a newer release later.	USD 1.19 million Calculation and evidence 1453364 − 258499 USD Exact free cash flow: 1194865 USD 1995-01-01 – 1995-12-31: 1453364 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 258499 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · POLAR MOLECULAR HOLDING CORP · 1995-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Free cash flow: 1194865 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1453364 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0000950137-97-001373.txt#2320 Input fundies:CapitalExpenditure: 258499 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0000950137-97-001373.txt#2323 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 2.49 million Exact value Exact value: -2487639 USD 1996-01-01 – 1996-12-31: -2487639 USD Inspect Net Income Open source Share or cite Citation for Net Income · POLAR MOLECULAR HOLDING CORP · 1996-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Net Income: -2487639 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2487639 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0000950137-97-001373.txt#2304 The citation records this snapshot. The page link may show a newer release later.	−USD 1.31 million Exact value Exact value: -1307460 USD 1996-01-01 – 1996-12-31: -1307460 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · POLAR MOLECULAR HOLDING CORP · 1996-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Operating Cash Flow: -1307460 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1307460 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0000950137-97-001373.txt#2320 The citation records this snapshot. The page link may show a newer release later.	USD 1.21 million Exact value Exact value: 1213470 USD 1996-01-01 – 1996-12-31: 1213470 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · POLAR MOLECULAR HOLDING CORP · 1996-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Capital Expenditure: 1213470 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1213470 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0000950137-97-001373.txt#2323 The citation records this snapshot. The page link may show a newer release later.	−USD 2.52 million Calculation and evidence -1307460 − 1213470 USD Exact free cash flow: -2520930 USD 1996-01-01 – 1996-12-31: -1307460 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 1213470 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · POLAR MOLECULAR HOLDING CORP · 1996-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Free cash flow: -2520930 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1307460 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0000950137-97-001373.txt#2320 Input fundies:CapitalExpenditure: 1213470 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0000950137-97-001373.txt#2323 The citation records this snapshot. The page link may show a newer release later.
2002 2001-04-01 – 2002-03-31	−USD 1.95 million Exact value Exact value: -1946000 USD 2001-04-01 – 2002-03-31: -1946000 USD Inspect Net Income Open source Share or cite Citation for Net Income · POLAR MOLECULAR HOLDING CORP · 2002-03-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Net Income: -1946000 USD Concept: fundies:NetIncome Period: 2001-04-01 to 2002-03-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3ANetIncome&period=2002-03-31&surface=latest&period_type=duration&start=2001-04-01&unit=USD&dimensions= Input fundies:NetIncome: -1946000 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001193125-04-061487.txt#5132 The citation records this snapshot. The page link may show a newer release later.	−USD 311,000 Exact value Exact value: -311000 USD 2001-04-01 – 2002-03-31: -311000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · POLAR MOLECULAR HOLDING CORP · 2002-03-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Operating Cash Flow: -311000 USD Concept: fundies:OperatingCashFlow Period: 2001-04-01 to 2002-03-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3AOperatingCashFlow&period=2002-03-31&surface=latest&period_type=duration&start=2001-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -311000 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001193125-04-061487.txt#5356 The citation records this snapshot. The page link may show a newer release later.	USD 2,000 Exact value Exact value: 2000 USD 2001-04-01 – 2002-03-31: 2000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · POLAR MOLECULAR HOLDING CORP · 2002-03-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Capital Expenditure: 2000 USD Concept: fundies:CapitalExpenditure Period: 2001-04-01 to 2002-03-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3ACapitalExpenditure&period=2002-03-31&surface=latest&period_type=duration&start=2001-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2000 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001193125-04-061487.txt#5403 The citation records this snapshot. The page link may show a newer release later.	−USD 313,000 Calculation and evidence -311000 − 2000 USD Exact free cash flow: -313000 USD 2001-04-01 – 2002-03-31: -311000 USD · Inspect Operating Cash Flow · Source 2001-04-01 – 2002-03-31: 2000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · POLAR MOLECULAR HOLDING CORP · 2002-03-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Free cash flow: -313000 USD Concept: free-cash-flow Period: 2001-04-01 to 2002-03-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -311000 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001193125-04-061487.txt#5356 Input fundies:CapitalExpenditure: 2000 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001193125-04-061487.txt#5403 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 3.32 million Exact value Exact value: -3319000 USD 2003-01-01 – 2003-12-31: -3319000 USD Inspect Net Income Open source Share or cite Citation for Net Income · POLAR MOLECULAR HOLDING CORP · 2003-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Net Income: -3319000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3319000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13252 The citation records this snapshot. The page link may show a newer release later.	−USD 765,000 Exact value Exact value: -765000 USD 2003-01-01 – 2003-12-31: -765000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · POLAR MOLECULAR HOLDING CORP · 2003-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Operating Cash Flow: -765000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -765000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13709 The citation records this snapshot. The page link may show a newer release later.	USD 2,000 Exact value Exact value: 2000 USD 2003-01-01 – 2003-12-31: 2000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · POLAR MOLECULAR HOLDING CORP · 2003-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Capital Expenditure: 2000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13814 The citation records this snapshot. The page link may show a newer release later.	−USD 767,000 Calculation and evidence -765000 − 2000 USD Exact free cash flow: -767000 USD 2003-01-01 – 2003-12-31: -765000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 2000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · POLAR MOLECULAR HOLDING CORP · 2003-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Free cash flow: -767000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -765000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13709 Input fundies:CapitalExpenditure: 2000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13814 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 3.2 million Exact value Exact value: -3195000 USD 2004-01-01 – 2004-12-31: -3195000 USD Inspect Net Income Open source Share or cite Citation for Net Income · POLAR MOLECULAR HOLDING CORP · 2004-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Net Income: -3195000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3195000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13252 The citation records this snapshot. The page link may show a newer release later.	−USD 1.12 million Exact value Exact value: -1121000 USD 2004-01-01 – 2004-12-31: -1121000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · POLAR MOLECULAR HOLDING CORP · 2004-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Operating Cash Flow: -1121000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1121000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13709 The citation records this snapshot. The page link may show a newer release later.	USD 3,000 Exact value Exact value: 3000 USD 2004-01-01 – 2004-12-31: 3000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · POLAR MOLECULAR HOLDING CORP · 2004-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Capital Expenditure: 3000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13814 The citation records this snapshot. The page link may show a newer release later.	−USD 1.12 million Calculation and evidence -1121000 − 3000 USD Exact free cash flow: -1124000 USD 2004-01-01 – 2004-12-31: -1121000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 3000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · POLAR MOLECULAR HOLDING CORP · 2004-12-31 POLAR MOLECULAR HOLDING CORP (edgar:908754) Free cash flow: -1124000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:00:14Z Snapshot: e5c9fe42bad40c872f5aa469318a272b1a35429fbbcbc296ed4de4257bac0b1d Dimensions: Consolidated View: https://fundies.io/companies/edgar/908754?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1121000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13709 Input fundies:CapitalExpenditure: 3000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908754/0001104659-06-001283.txt#13814 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

42 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000908754, 908754, edgar:908754

Also known as MURDOCK COMMUNICATIONS CORP

POLAR MOLECULAR HOLDING CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2004 2004-01-01 – 2004-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation